Adverse event totals15

The totals the trial posted for each group.

1 to 15 of 15

Total	Group	Affected	At risk
Total, all-cause mortality	LIK066 2.5mg	0	15
Total, all-cause mortality	LIK066 10mg	1	16
Total, all-cause mortality	LIK066 50mg	0	30
Total, all-cause mortality	EMPA 25mg	0	30
Total, all-cause mortality	Placebo	1	33
Total, other adverse events	LIK066 2.5mg	7	15
Total, other adverse events	LIK066 10mg	6	16
Total, other adverse events	LIK066 50mg	8	30
Total, other adverse events	EMPA 25mg	12	30
Total, other adverse events	Placebo	9	33
Total, serious adverse events	LIK066 2.5mg	2	15
Total, serious adverse events	LIK066 10mg	2	16
Total, serious adverse events	LIK066 50mg	3	30
Total, serious adverse events	EMPA 25mg	5	30
Total, serious adverse events	Placebo	3	33

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT03152552/event-totals